David P. Hochman - 16 May 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Chief Executive Officer and Chairperson, Director
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
16 May 2024
Net transactions value
+$24,950
Form type
4
Filing time
20 May 2024, 16:15:27 UTC
Previous filing
10 May 2024
Next filing
26 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $9,500 +2,000 +0.61% $4.75 329,502 16 May 2024 By the DPH 2008 Trust F1
transaction OBIO Common Stock Award $15,450 +3,000 +0.91% $5.15 332,502 17 May 2024 By the DPH 2008 Trust F2
holding OBIO Common Stock 3,140 16 May 2024 By the NSH 2008 Family Trust
holding OBIO Common Stock 565,498 16 May 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $5.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Chief Executive Officer and Chairperson